Metoprolol Succinate
Product Images NDC 71610-496

4 FDA label images from Aphena Pharma Solutions - Tennessee, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 71610-496). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Bottle Label 200 mg (71610 0496 45)

Bottle Label 200 mg (71610 0496 45)
METOPROLOL SUCCINATE ER 200 mg tablet label from Aphena Pharma Solutions - Tennessee, LLC. The label includes 45 tablets with storage instructions, manufacturer (AstraZeneca AB, Sodertalje, Sweden), and repackager information. It shows product NDC 71610-0496-45 and contains regulatory details including lot number, expiration date, and barcodes.*
FDA Label Image

Aphena Pharma Solutions (TN)

Aphena Pharma Solutions (TN)
FDA Label Image

Structuralformula (Image 01)

Structuralformula (Image 01)
Chemical structure of metoprolol succinate, showing the molecular arrangement of metoprolol and succinate components. The depiction includes hydroxyl, ether, and amine groups attached to a benzene ring, along with the succinate moiety represented by carboxylic acid groups and carbon chains.*
FDA Label Image

Merit Graphic (Image 02)

Merit Graphic (Image 02)
A forest plot chart showing results for subgroups in the MERIT-HF study. It compares the relative risk and 95% confidence intervals of total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure between metoprolol succinate extended release tablets and placebo across various patient subgroups such as geography, NYHA class, ejection fraction, etiology, sex, race, myocardial infarction history, diabetes, hypertension, and heart rate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.